0 0
Read Time:3 Minute, 53 Second
Psoriatic Arthritis Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030

Psoriatic Arthritis Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Psoriatic Arthritis Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, April 6, 2021 /EINPresswire.com/ — According to the new market research report ‘Psoriatic Arthritis Treatment COVID-19 Growth And Change To 2030’ published by The Business Research Company, the psoriatic arthritis treatment market is expected to reach $11.34 billion in 2025 at a CAGR of 9%. The rise in the prevalence of psoriasis & psoriatic arthritis disease boosted the growth of the psoriatic arthritis treatment market. Psoriasis (Pso) and psoriatic arthritis (PsA) are inflammatory disorders that can severely impair health and quality of life.

Request For A Sample For The Global Psoriatic Arthritis Treatment Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp

The psoriatic arthritis treatment market consists of the sale of psoriatic arthritis drugs used for the treatment of psoriatic arthritis by entities producing drugs for psoriatic arthritis. Psoriasis arthritis is a chronic inflammatory joint disease that is associated with psoriasis, whose symptoms vary from person to person.

The development of novel drugs such as Janus kinase (JAK) inhibitors for treating psoriatic arthritis is shaping the market. Janus kinase (JAK) inhibitors are orally administered small molecules emerging as a novel treatment for psoriatic arthritis patients. There are three JAK inhibitors approved for the treatment of autoimmune diseases – tofacitinib, baricitinib, and upadacitinib. Among them, Xeljanz (tofacitinib) and Xeljanz (tofacitinib) XR are the first Janus kinase (JAK) inhibitors that have been approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

The global psoriatic arthritis treatment market is further segmented based on drug class, route of administration, distribution channel and geography.

By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Biologics, Others.

By Route Of Administration: Oral, Parenteral, Topical.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

By Geography: The global psoriatic arthritis treatment market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Psoriatic Arthritis Treatment Market At:
https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatment-global-market-report-2020-30-covid-19-growth-and-change

Psoriatic Arthritis Treatment Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides psoriatic arthritis treatment market overviews, analyzes and forecasts market size and growth for the global psoriatic arthritis treatment market, market share, psoriatic arthritis treatment market players, psoriatic arthritis treatment market segments and geographies, psoriatic arthritis treatment market’s leading competitors’ revenues, profiles and market shares. The psoriatic arthritis treatment market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read Psoriatic Arthritis Treatment Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Psoriatic Arthritis Treatment Market Organizations Covered: AbbVie, Amgen, Johnson & Johnson, Bristol-Myers Squibb Company, Celgene Corporation, Novartis, Eli Lilly And Company.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Here is a list of reports from The Business Research Company similar to the Psoriatic Arthritis Treatment Global Market Report 2021:

Arthritis Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodies-global-market-report-2020-30-covid-19-growth-and-change

Arthroscopy Devices And Equipment Global Market Report 2021: COVID-19 Impact And Recovery To 2030
https://www.thebusinessresearchcompany.com/report/arthroscopy-devices-and-equipment-global-market-report

Biosimilar Interleukins Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/biosimilar-interleukins-global-market-report-2020-30-covid-19-growth-and-change

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *